espryx.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Specialty Chemicals - Evonik |
| Description | New lipid production facility in the Leading beyond Chemistry. Our 32,000 employees are driven by one idea: No product is so perfect that you can’t improve it. To make that happen, we go beyond |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 149.216.106.61 |
| Location | Germany |
Related Websites
| Site | Rank |
More to Explore
espryx.com Valuation
|
US$906,073
Last updated: 2022-11-16 08:04:28
espryx.com has Semrush global rank of 11,681,518. espryx.com has an estimated worth of US$ 906,073, based on its estimated Ads revenue. espryx.com receives approximately 104,547 unique visitors each day. Its web server is located in Germany, with IP address 149.216.106.61. According to SiteAdvisor, espryx.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$906,073 |
| Daily Ads Revenue | US$837 |
| Monthly Ads Revenue | US$25,092 |
| Yearly Ads Revenue | US$301,095 |
| Daily Unique Visitors | 6,970 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| espryx.com. | A | 3600 | IP: 149.216.106.61 |
| espryx.com. | NS | 21600 | NS Record: dns1.evonik.com. |
| espryx.com. | NS | 21600 | NS Record: qdns2.degussa.de. |
| espryx.com. | TXT | 3600 | TXT Record: swisssign-check=3mSHscPpJ5s4bpxf9Ywx0mtqWHIE6yjdgFR6Gzudv1 |
| espryx.com. | TXT | 3600 | TXT Record: google-site-verification=UmARBbPmsuIswdXruhMzIEuuau9CZnWhNk_MTfHYp0o |
HtmlToTextCheckTime:2022-11-16 08:04:28
| Evonik worldwide Languages Deutsch English Company Products and Solutions Responsibility Investor Relations Media Career Home Company Products and Solutions Responsibility Investor Relations Media Career New lipid production facility in the U.S. The new plant at Evonik’s Tippecanoe site in Lafayette, Indiana, will broadly position the Group for future growth in novel mRNA-based therapies beyond COVID-19 vaccines and strengthen its leading role as a strategic partner for innovative pharmaceutical companies worldwide. ... MORE Health Care Jun 02, 2022 Evonik invests US$220 million in partnership with the U.S. Government to build new lipid production facility for mRNA-based therapies in the U.S. The new plant will broadly position the Group for future growth in mRNA-based therapies and strengthen its leading role as a strategic partner for pharmaceutical companies worldwide. ... MORE Health Care Jun 02, 2022 Evonik invests US$220 million in partnership with the U.S. Government to build |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Thu, 12 May 2022 09:39:59 GMT Location: http://corporate.evonik.com/en/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 301 Moved Permanently Date: Thu, 12 May 2022 09:39:59 GMT Location: https://corporate.evonik.com/en/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Thu, 12 May 2022 09:40:00 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding,Origin cache-control: max-age=20, public x-content-type-options: nosniff x-xss-protection: 1; mode=block referrer-policy: no-referrer, strict-origin-when-cross-origin permissions-policy: accelerometer=(), autoplay=(self), camera=(), cross-origin-isolated=(), display-capture=(), document-domain=(), encrypted-media=(), fullscreen=(self), geolocation=(), gyroscope=(), keyboard-map=(), magnetometer=(), microphone=(), midi=(), payment=(), picture-in-picture=(), publickey-credentials-get=(), screen-wake-lock=(), sync-xhr=(), usb=(), web-share=(), xr-spatial-tracking=(), clipboard-read=(), clipboard-write=(), hid=(), idle-detection=(), serial=() content-security-policy: default-src 'self' data: https:; script-src 'self' data: 'unsafe-inline' 'unsafe-eval' https: https://c.iad.oracleinfinity.io blob:; style-src 'self' data: 'unsafe-inline' https:; img-src 'self' data: https:; frame-ancestors 'self' https://*.beocms.com https://*.beocms.de https://communities.evonik.com; frame-src 'self' data: https: blob:; connect-src 'self' data: https:; media-src 'self' data: https: blob: x-cacheable: BACKEND VALUE CACHE-CONTROL: 'max-age=20, public' COMPUTED TTL: '0.000' HEADER GRACE: '' COMPUTED GRACE: '86400.000' x-varnish: 21569234 age: 0 via: 1.1 varnish (Varnish/6.1) strict-transport-security: max-age=15552000; preload Via: 1.1 corporate.evonik.com |
espryx.com Whois Information
Domain Name: ESPRYX.COM Registry Domain ID: 2019367993_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2022-04-02T05:07:55Z Creation Date: 2016-04-06T14:38:16Z Registry Expiry Date: 2023-04-06T14:38:16Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.EVONIK.COM Name Server: QDNS2.DEGUSSA.DE DNSSEC: unsigned >>> Last update of whois database: 2022-05-12T10:02:36Z <<< |